Products for Research Use Only
RegisterLogin

Lomtegovimab

CAT: 0804-HY-P99710-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99710-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Lomtegovimab (BI 767551) is a human anti-SARS-COV-2 spike glycoprotein monoclonal antibody. Lomtegovimab binds and neutralizes SARS-CoV-2. Lomtegovimab shows antiviral efficacy. Lomtegovimab has the potential for the research of COVID-19[1][2].
CAS Number
2550869-33-3
Product Name Alternative
BI 767551; DZIF-10c
UNSPSC
12352203
Target
SARS-CoV
Type
Inhibitory Antibodies
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/lomtegovimab.html
Purity
99.94
Solubility
10 mM in DMSO
Smiles
[Lomtegovimab]
Molecular Weight
(145.58 kDa)
References & Citations
[1]Halwe S, et al. Intranasal Administration of a Monoclonal Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection. Viruses. 2021 Jul 29;13 (8) :1498.|[2]Halwe S, et al. Intranasal Administration of a Monoclonal Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection. Viruses. 2021 Jul 29;13 (8) :1498.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 3

Alternative Products

CatalogName
MBS5818991Lomtegovimab
GTR18337694Lomtegovimab Antibody
E55B0861Lomtegovimab (Reference antibody)
VK565136-01Research Grade Lomtegovimab
ICH5654-5mgLomtegovimab Biosimilar - Research Grade
GTR18697272-01Lomtegovimab Human Monoclonal Antibody
GTR18780668-01(Lomtegovimab) Biosimilar Reference Antibody
A135569Lomtegovimab Biosimilar (Monoclonal, IgG1, kappa)
PX-TA1801-01Lomtegovimab Biosimilar - Anti-Spike RBD mAb - Research Grade
RA0655-01Lomtegovimab (Biosimilar Reference Antibody) (SARS-CoV-2 Spike RBD)

Popular Products